Arm Holdings Has Fallen 28% in the Past Month. Should You Buy Before July 29 Earnings?

Arm stock has shed nearly a third of its value in just one month, yet the company's AI data center pipeline tells a very different story heading into Wednesday's earnings report.

Published July 27, 2026, 1:20pm ET · 2 min read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

A wide exterior view of a modern, white building with large reflective windows, featuring the 'arm' logo in blue letters on its upper facade. Bare-branched trees stand in front, with green shrubs and white planters lining the base of the building. The sky is clear blue.
The Arm Holdings headquarters stands as the company looks to expand its market opportunities beyond its traditional smartphone dominance. © Sundry Photography / iStock Editorial via Getty Images

Arm Holdings (NASDAQ:ARM | ARM Price Prediction) enters Wednesday’s Q1 FY2027 earnings with its stock down nearly 28% over the past month. Meanwhile, the company has already booked more than $2 billion in demand for its new AGI data center CPU across fiscal 2027 and 2028, giving investors a measurable catalyst behind the next phase of growth.

Arm Has Already Booked $2 Billion in AI CPU Demand

On the Q4 earnings call, CEO Rene Haas confirmed “more than $2 billion of customer demand across fiscal 2027 and fiscal 2028″ for the Arm AGI CPU, double what was announced at launch six weeks earlier. Meta is the lead co-developer.

OpenAI, Cerebras, SAP, and Cloudflare are integrating. The data center CPU TAM is expected to be over $100 billion by 2030, and Arm currently holds roughly 50% CPU compute share among top hyperscalers. Data center royalty more than doubled year-over-year in FY2026 and is expected to double again in FY2027.

ARM analyst ratings

With 27 buy ratings against 2 sells and an average analyst price target of $300.73, $ARM appears to offer upside from its current price of $254.50.

Free Cash Flow Nearly Quintupled Last Year

FY2026 free cash flow reached $882 million, up 395.51% year-over-year, with operating cash flow of $1.524 billion (+283.88%) and gross margin at 92.48%. This is Arm’s third consecutive year of 20%+ revenue growth, with $4.92 billion in FY2026 revenue (+22.79% YoY). ACV climbed 22% YoY to $1.66 billion, giving forward visibility on the licensing base before royalties compound.

ARM earnings explorer

Why Nvidia’s AI Growth Also Benefits Arm

NVIDIA’s (NASDAQ:NVDA) next-generation Vera CPU is Arm-based, so every Vera rack pays Arm a royalty. NVIDIA already trades at a premium valuation, meaning that a marginal dollar of AI infrastructure spend is more valuable on Arm’s smaller $277.71 billion market cap.

Qualcomm (NASDAQ:QCOM) looks cheaper than ARM at a lower P/E multiple, but revenue fell 3.5% in its most recent quarter, and QCOM has a gross margin of 55.4% versus Arm’s 92%.

Lower Margins Are Funding Arm’s Next Growth Engine

Arm’s higher R&D spending is pressuring near-term margins, but it is also funding a data center business that management expects to reach $15 billion in annual revenue by FY2031. With free cash flow up nearly 400%, more than $2 billion in AGI CPU demand already booked, and the stock down 28% in one month, Wednesday’s earnings could reveal whether the pullback has created a buying opportunity.

Contact [email protected] for any questions or corrections.

Thomas Richmond

Thomas Richmond is a financial writer and content strategist with 5+ years of experience covering stocks and financial markets. He has published over 500 articles focused on individual stock analysis, helping investors better understand business fundamentals, stock valuations, and long-term opportunities.

Thomas previously served as a Content Lead at TIKR, a stock research platform, where he helped scale the company’s blog to hundreds of articles per month and contributed to a weekly newsletter reaching more than 100,000 investors.

Outside of work, Thomas enjoys weight lifting and soccer.

All articles →